Sign in and upgrade to a paid plan to export financials as CSV.

Chandra Bhagat Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 542934
₹49.40
▼ -0.05 (-0.10%)
Sept. 28, 2026 · BSE · bse_bhavcopy
Quality
80/100
Strong
Valuation
—/100
Data unavailable
Momentum
46/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-26.3
Free Cash Flow
₹8 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
1.50
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 3 met
  • Yes Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 1 met
  • No 1-year return beats the industry median

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.1%
Low 49.4000 · High 49.4000
1W return
-5.1%
Low 49.4000 · High 52.9900
1M return
-2.0%
Low 44.6500 · High 52.9900
52W return
-26.3%
Low 41.0000 · High 52.9900
Lifetime High ₹154.3500 (Dec. 21, 2023)
Lifetime Low ₹31.1500 (April 16, 2020)

Full price history and technicals →

EMA & SMA

Bullish1
Bearish5
5D
49.3
10D
49.8
20D
55.1
50D
73.0
100D
89.2
200D
109.3

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
95.5%
Month avg. delivery
95.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

49.40
Pivot
First resistance49.40
Second resistance49.40
Third resistance49.40
First support49.40
Second support49.40
Third support49.40
Day RSI37.2
Day MFI70.1
Day MACD-8.67
Day MACD signal-10.57

Beta

1M—
3M—
1Y—
3Y-1.41

Price change analysis

↓ -2.0%
Over 1 Month
LowHigh
44.6552.99
↓ -26.3%
Over 3 Months
LowHigh
41.0052.99
↓ -26.3%
Over 6 Months
LowHigh
41.0052.99
↓ -26.3%
Over 1 Year
LowHigh
41.0052.99
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #None of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter73.02%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 72.19% to 73.02% in Mar 2026 qtr

Historical fii holding

All shareholding details →

DateClientDealActionQuantityPriceExchange
16 Jun 2026 TEAM ANAMIKA ALGO LIMITED Bulk Sell 49,000 44.0000 BSE
22 May 2026 TEAM ANAMIKA ALGO LIMITED Bulk Sell 60,000 39.9300 BSE
22 May 2026 BENGAL TIGER CAPITAL ADVISORS LLP Bulk Buy 62,000 39.9000 BSE
27 Feb 2026 PRACHI PRANAV BHAGAT Bulk Buy 62,000 39.8900 BSE
28 Jul 2025 PRACHI PRANAV BHAGAT Bulk Buy 39,000 53.8400 BSE
19 Feb 2025 M7 GLOBAL FUND PCC - NOLANA Bulk Buy 46,000 64.6100 BSE
28 Nov 2024 PIYUSH SECURITIES PVT LTD Bulk Sell 63,000 68.8400 BSE
28 Nov 2024 PRACHI PRANAV BHAGAT Bulk Buy 64,000 68.8400 BSE
27 Nov 2024 KAPIL AGARWAL HUF . Bulk Sell 50,000 65.0000 BSE
27 Nov 2024 PIYUSH SECURITIES PVT LTD Bulk Buy 63,000 64.9200 BSE

All bulk and block deals →

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Insider Trading / SAST Chandra Bhagat Pharma Ltd - 542934 - Closure of Trading Window
30 Sep 2026 Company Update Chandra Bhagat Pharma Ltd - 542934 - Announcement under Regulation 30 (LODR)-Change in Management

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 26.3% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Chandra Bhagat Pharma Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.